162 related articles for article (PubMed ID: 11122363)
1. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Eur J Neurosci; 2000 Dec; 12(12):4525-35. PubMed ID: 11122363
[TBL] [Abstract][Full Text] [Related]
2. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients.
François C; Savy C; Jan C; Tande D; Hirsch EC; Yelnik J
J Comp Neurol; 2000 Sep; 425(1):121-9. PubMed ID: 10940946
[TBL] [Abstract][Full Text] [Related]
4. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Schneider JS; Dacko S
Brain Res; 1991 Aug; 556(2):292-6. PubMed ID: 1682010
[TBL] [Abstract][Full Text] [Related]
5. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.
Parent A; Lavoie B; Smith Y; Bédard P
Adv Neurol; 1990; 53():111-6. PubMed ID: 1978512
[TBL] [Abstract][Full Text] [Related]
6. Physiological studies of information processing in the normal and Parkinsonian basal ganglia: pallidal activity in Go/No-Go task and following MPTP treatment.
Morris G; Hershkovitz Y; Raz A; Nevet A; Bergman H
Prog Brain Res; 2005; 147():285-93. PubMed ID: 15581713
[TBL] [Abstract][Full Text] [Related]
7. Computational physiology of the basal ganglia in Parkinson's disease.
Rivlin-Etzion M; Elias S; Heimer G; Bergman H
Prog Brain Res; 2010; 183():259-73. PubMed ID: 20696324
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
9. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates.
Soghomonian JJ; Pedneault S; Audet G; Parent A
J Neurosci; 1994 Oct; 14(10):6256-65. PubMed ID: 7931578
[TBL] [Abstract][Full Text] [Related]
10. Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.
Zhang J; Russo GS; Mewes K; Rye DB; Vitek JL
Exp Neurol; 2006 Jun; 199(2):446-53. PubMed ID: 16487515
[TBL] [Abstract][Full Text] [Related]
11. MPTP-Induced pallidal lesions in rhesus monkeys.
Zhang Z; Zhang M; Ai Y; Avison C; Gash DM
Exp Neurol; 1999 Jan; 155(1):140-9. PubMed ID: 9918713
[TBL] [Abstract][Full Text] [Related]
12. [Experimental models of Parkinson's disease].
Féger J; Pessigliore M; François C; Tremblay L; Hirsch E
Ann Pharm Fr; 2002 Jan; 60(1):3-21. PubMed ID: 11976545
[TBL] [Abstract][Full Text] [Related]
13. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
14. Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Bezard E; Boraud T; Chalon S; Brotchie JM; Guilloteau D; Gross CE
Neuroscience; 2001; 103(1):117-23. PubMed ID: 11311792
[TBL] [Abstract][Full Text] [Related]
15. Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.
Stephenson DT; Li Q; Simmons C; Connell MA; Meglasson MD; Merchant K; Emborg ME
Neurobiol Dis; 2005 Nov; 20(2):347-59. PubMed ID: 15882945
[TBL] [Abstract][Full Text] [Related]
16. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia.
Nevet A; Morris G; Saban G; Fainstein N; Bergman H
J Neurophysiol; 2004 Oct; 92(4):1973-81. PubMed ID: 15115785
[TBL] [Abstract][Full Text] [Related]
17. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism.
Leblois A; Meissner W; Bioulac B; Gross CE; Hansel D; Boraud T
Eur J Neurosci; 2007 Sep; 26(6):1701-13. PubMed ID: 17880401
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus.
Hedreen JC
J Comp Neurol; 1999 Jul; 409(3):400-10. PubMed ID: 10379826
[TBL] [Abstract][Full Text] [Related]
19. Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.
Debeir T; Ginestet L; François C; Laurens S; Martel JC; Chopin P; Marien M; Colpaert F; Raisman-Vozari R
Exp Neurol; 2005 Jun; 193(2):444-54. PubMed ID: 15869947
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys.
Parent A; Asselin MC; Côté PY
Adv Neurol; 1996; 69():73-7. PubMed ID: 8615187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
